Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

[Regulatory classification of AI-enabled products for medical use on the basis of the EU AI Act and MDR/IVDR].

PMID: 40643665 · 2025

JournalBundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
Year2025
PMID40643665

Abstract

The use of artificial intelligence (AI) in healthcare offers great potential but also presents regulatory challenges. The EU Artificial Intelligence Act (AIA), the Medical Device Regulation (MDR), and the Regulation on in vitro diagnostic medical devices (IVDR) establish the framework for the safe and ethical use of AI-based medical devices in Europe.When assessing the regulatory classification of AI software or products with AI components, it must be determined-based on the intended purpose def

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.